
Hillhouse Ventures
Description
Hillhouse Ventures is the dedicated early-stage investment arm of Hillhouse Capital, a globally renowned investment firm. Established to identify and nurture nascent companies with significant growth potential, Hillhouse Ventures primarily focuses on early-stage startups, typically from Seed to Series B rounds. While its parent company, Hillhouse Capital, is known for its long-term, value-oriented investments across various stages, Hillhouse Ventures specifically targets the foundational phases of a company's lifecycle, providing crucial capital and strategic support during their formative years.
The firm's investment strategy is sector-agnostic but demonstrates a strong inclination towards disruptive technologies, healthcare innovation, advanced manufacturing, and consumer brands. Geographically, Hillhouse Ventures has a dominant presence in China, where it leverages Hillhouse Capital's deep market insights and extensive network. However, it has also expanded its reach into promising markets across Southeast Asia, including Singapore, aligning with the region's burgeoning startup ecosystem. In 2021, Hillhouse Ventures successfully closed its fifth early-stage fund, raising approximately $1.5 billion, underscoring its significant capital deployment capabilities and commitment to early-stage ventures.
Hillhouse Ventures typically participates in rounds ranging from Series A to Series B, although it may consider exceptional Seed-stage opportunities. Their initial cheque sizes generally fall within a substantial range, often starting from around $5 million for a lead investment in a promising Series A round. For more mature early-stage companies, particularly those in Series B, their investments can scale up to $50 million, reflecting their capacity to provide significant growth capital. Beyond financial investment, Hillhouse Ventures is known for its hands-on approach, offering strategic guidance, operational expertise, and access to Hillhouse Capital's vast ecosystem of resources and industry connections, which is critical for early-stage companies navigating complex growth trajectories.
This strategic approach allows Hillhouse Ventures to not only provide essential funding but also to act as a long-term partner, helping startups scale operations, refine business models, and achieve market leadership. Their reputation for rigorous due diligence combined with a founder-friendly approach has made them a sought-after investor in the competitive early-stage landscape, particularly across Asia.
Investor Profile
Hillhouse Ventures has backed more than 24 startups, with 11 new investments in the last 12 months alone. The firm has led 9 rounds, about 38% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in China, Singapore, United States.
- Strong thematic focus on Manufacturing, Biotechnology, Artificial Intelligence (AI).
- Led 5 rounds in the past year.
- Typical check size: $5M – $50M.
Stage Focus
- Series B (29%)
- Series A (25%)
- Seed (25%)
- Private Equity (4%)
- Series C (4%)
- Series D (4%)
- Angel (4%)
- Series Unknown (4%)
Country Focus
- China (83%)
- Singapore (4%)
- United States (4%)
Industry Focus
- Manufacturing
- Biotechnology
- Artificial Intelligence (Ai)
- Health Care
- Robotics
- Medical
- Biopharma
- Pharmaceutical
- Software
- Electronics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.